2019台灣生技月 Bio Taiwan 生物科技大展

2019 台灣生技月 南港展覽館

SATELLITE EVENTS

International Pancreatic Cancer Forum

International Pancreatic Cancer Forum -
Global Trends in FOLFIRINOX Treatment for Pancreatic Cancer

Organizer: Taiwan Pancreas Society, Taiwan Oncology Society, SynCore Biotechnology, Taiwan Bio Industry Organization
Date & Time:  27th  July, 2019 13:00-17:20
Venue: Conference Rm 401, 4F, Hall 1, Taipei Nangang Exhibition Hall 
             (No. 1, Jingmao 2nd Road, Nangang District, Taipei)
Registration Link: https://bit.ly/2N7QnBg      [ Free Admission / Pre-registration Required ]

Agenda:

Time

Topic

Speaker

13:00 - 13:30

Reception

 

13:30 - 13:50

Opening Remarks

Dr. Shou-Mei Wu, Director General of Taiwan Food and Drug Administration 
Dr. Li-Tzong Chen, President of Taiwan Oncology Society
Dr. Ta-Sen Yeh, President of Taiwan Pancreas Society
Dr. Johnsee Lee, Chairman of Taiwan Bio Industry Organization
Dr. Muh-Hwan Su, General Manager of SynCore Biotechnology

Session Moderator: Dr. Ta-Sen Yeh, President of Taiwan Pancreas Society

13:50 - 14:20

The Experience of mFOLFIRINOX for Patients with Pancreatic Cancer

Dr. Li Yuan Bai
Director, Division of Hematology and Oncology, China Medical University Hospital, Taiwan

14:20 - 14:50

The Korea Experience of FOLFIRINOX in Pancreatic Cancer

Dr. Hong Jae Chon
Associate Professor, Medical Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Gyeonggi-Do, Korea ​

14:50 - 15:10

Coffee Break

 

Session Moderator: Dr. Li-Tzong Chen, President of Taiwan Oncology Society

15:10 - 15:40

The U.S. Experience of FOLFIRINOX in Pancreatic Cancer

Dr. Philip Agop Philip
Karmanos Cancer Institute, Wayne State University,
Leader, GI and Neuroendocrine Oncology, Vice President of Medical Affairs USA

15:40 - 16:10

Retrospective Analysis of FOLFIRINOX Treatment in Advanced Pancreatic Cancer in Out Center

Dr. Zsuzsanna Pápai
Head of the Oncology Department, Medical Center- Hungarian Defense Forces, Budapest, Hungary

16:10 - 16:40

The France Experience of FOLFIRINOX in Pancreatic Cancer

Dr. Jean-Philippe Metges
Associate Professor & Oncology Physician, Institute of Oncology and Hematology, Brest CHRU, France

16:40 - 17:10

Panel Discussion

Dr. Li Yuan Bai, Director, China Medical University Hospital, Taiwan
Dr. Hong Jae Chon, Associate Professor, CHA Bundang Medical Centera, South Korea
Dr. Jean-Philippe Metges, Associate Professor, Brest CHRU, France
Dr. Philip Agop Philip, Vice President of Medical Affairs USA
Dr. Zsuzsanna Pápai, Head of Oncology Department, Hungary

Dr. Li-Tzong Chen, President of Taiwan Oncology 
Dr. Ta-Sen Yeh, President of Taiwan Pancreas Society
Dr. Muh-Hwan Su, General Manager, SynCore Biotechnology

17:10-17:20 Closing Remark Dr. Muh-Hwan SuGeneral Manager, SynCore Biotechnology


Contact: 
TEL:02-2760-3688*2854 Ms. Hsiao
Email Add:YHHsiao2@syncorebio.com